Cargando…
SOCS1 blocks G1-S transition in hepatocellular carcinoma by reducing the stability of the CyclinD1/CDK4 complex in the nucleus
Inhibitors of the CDK family of proteins have been approved for the treatment of a variety of tumours; however, the development of new drugs administered in combination with CDK inhibitors is expected to improve the therapeutic effect. We identified the function of suppressor of cytokine signalling...
Autores principales: | Ding, Jun, Xu, Kangdi, Sun, Suwan, Qian, Chao, Yin, Shengyong, Xie, Haiyang, Zhou, Lin, Zheng, Shusen, Zhang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066915/ https://www.ncbi.nlm.nih.gov/pubmed/32096766 http://dx.doi.org/10.18632/aging.102865 |
Ejemplares similares
-
USP5 Sustains the Proliferation of Glioblastoma Through Stabilization of CyclinD1
por: Li, Gen, et al.
Publicado: (2021) -
Cul4B promotes the progression of ovarian cancer by upregulating the expression of CDK2 and CyclinD1
por: Duan, Peng-jing, et al.
Publicado: (2020) -
Overexpression of cdk4 and cyclinD1 triggers greater expansion of neural stem cells in the adult mouse brain
por: Artegiani, Benedetta, et al.
Publicado: (2011) -
CyclinD1, a prominent prognostic marker for endometrial diseases
por: Liang, Shuo, et al.
Publicado: (2013) -
Influence of cyclin D1 splicing variants expression on breast cancer chemoresistance via CDK4/CyclinD1‐pRB‐E2F1 pathway
por: Wang, Jing, et al.
Publicado: (2023)